Bildkälla: Stockfoto

Asarina Pharma Q1: Menstrual Migraine Readout Approaches - Redeye

There is nothing that surprises us in Asarina Pharma’s financials. We are now eyeing the phase 2a readout in menstrual migraine, expected by the end of this quarter.

There is nothing that surprises us in Asarina Pharma’s financials. We are now eyeing the phase 2a readout in menstrual migraine, expected by the end of this quarter.
Börsvärldens nyhetsbrev
ANNONSER